Quarterly Result15 Nov 2025, 05:32 am
Kapil Cotex Ltd Announces Q3 2025 Financial Results with Net Loss of Rs. 32.14 Lakhs
AI Summary
Kapil Cotex Ltd, now known as Skybiotech Healthcare Limited, has announced its un-audited financial results for the quarter and half year ended on 30th September 2025. The company reported a net loss of Rs. 32.14 Lakhs for the quarter ended on 30th September 2025. The financial results were reviewed and approved by the Board of Directors in a meeting held on 14th November 2025. The company's management is responsible for preparing the statement in accordance with Ind AS 34, Companies Act, 2013 and other applicable accounting principles.
Key Highlights
- Kapil Cotex Ltd announced its Q3 2025 financial results.
- The company reported a net loss of Rs. 32.14 Lakhs for the quarter ended on 30th September 2025.
- The financial results were reviewed and approved by the Board of Directors in a meeting held on 14th November 2025.
- The company's management is responsible for preparing the statement in accordance with Ind AS 34, Companies Act, 2013 and other applicable accounting principles.
- The financial results include the performance of the subsidiary company, Skybiotech Life Sciences Private Limited.
Price Impact
More from KAPILCO